TAO-MIN HUANGVIN-CENT WU2021-08-242021-08-2420141016-7390https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902269444&partnerID=40&md5=f80feb8c11352df3dc4dc0141d155c28https://scholars.lib.ntu.edu.tw/handle/123456789/579355Contrast-induced acute kidney injury (CI-AKI) is closely associated with poor outcomes, especially in patients undergoing invasive cardiac angiography. Emerging evidence prompts that these poor outcomes are noted related to contrast medium per se, but are closely correlated with the underlying illness of patients undergoing cardiac angiography. We will discuss about recent evidences of such concepts based on recent epidemiologic findings. Novel biomarkers are the hottest topic in acute kidney injury research. We will discuss about the role of the most promising biomarker on early diagnoses of CI-AKI. In the final paragraph, recent advances in medical prevention for CI-AKI will be discussed.[SDGs]SDG3biological marker; acute kidney failure; article; contrast induced acute kidney injury; early diagnosis; human; percutaneous coronary interventionjournal article2-s2.0-84902269444